Reaktionsgleichung
Cl.[CH2:2]1[C:6]2([CH2:11][CH2:10][NH:9][CH2:8][CH2:7]2)[CH2:5][CH2:4][O:3]1.FC(F)(F)S([O-])(=O)=O.[N:20]1([S:25](N2C=C[NH+](C)C2)(=[O:27])=[O:26])[CH:24]=[CH:23][N:22]=[CH:21]1>>[N:20]1([S:25]([N:9]2[CH2:10][CH2:11][C:6]3([CH2:2][O:3][CH2:4][CH2:5]3)[CH2:7][CH2:8]2)(=[O:27])=[O:26])[CH:24]=[CH:23][N:22]=[CH:21]1Komponenten
3
Versuchsvorschrift
8-(Imidazole-1-sulfonyl)-2-oxa-8-aza-spiro[4.5]decane was prepared in accordance with step A of the general method described in example 76 from 2-oxa-8-aza-spiro[4.5]decane hydrochloride and 3-(1H-imidazol-1-ylsulfonyl)-1-methyl-1H-imidazolium trifluoromethanesulfonate; MS: m/e=216.5 (M+H+).
Quellen und Nachweise
- ORD-Eintrag
- ord-3e26916377d94dd6a4ee098590136e7f
- Quelldatensatz
- uspto-grants-2012_05
- Patentnummer
- US08183380B2
Verknüpfte Notizen
Wird geladen…